Our latest article in Applied Clinical Trials Online discusses the Role of Data Science and Understanding Patient Behavior. … Read More
Our latest article in PMPS discusses how non-adherence to medication has been costing lives and money for decades but SmartPackaging solutions are now solving the age-old problem.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2021, pages 46-49. © Samedan Ltd
AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.
AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems … Read More
MEMS® has been a part of successful adherence research for more than 30 years.Download this adherence compendium and find out how digital medication adherence monitoring increases the impact of academic research findings.
By establishing itself in the U.S., the Group aims to strengthen its business and maintain its position as market leader in digital adherence monitoring systems. Joe Keenan will lead the business development for the pharma and biotech industry in North America. … Read More
Electronic monitoring, a digital technology based on smart packages, enables the most objective and precise adherence monitoring. By using an evidence-based digital adherence monitoring system, Sponsors and HCPs improve drug efficacy by managing patient adherence to the medications. In this … Read More
50 % of patients involved in clinical trials do not take their medication as prescribed, resulting in underestimated drug efficacy and delayed approval of the investigational product. Poor medication adherence is thus a threat to drug development. Stop using unreliable … Read More
Recently, the FDA (Mar 2019) and the EMA (Feb 2020) have finalized guidances to monitor and mitigate the risk of patient non-adherence to the treatments tested in clinical trials. Under the auspices of the International Society for Medication Adherence (ESPACOMP), an … Read More